Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)GlobeNewsWire • Friday
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)Business Wire • Tuesday
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business UpdateGlobeNewsWire • 03/20/24
Alvotech Announces Webcast of Full Year 2023 Financial Results on March 21, 2024, at 8:00 am ETGlobeNewsWire • 03/05/24
Alvotech Accepts Offer for the Sale of Shares for a value of approximately USD 166 million at a Purchase price of USD 16.41 (ISK 2,250) per ShareGlobeNewsWire • 02/26/24
Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®Business Wire • 02/24/24
Alvotech Announces Expected Global Market Entry Dates for AVT04 Biosimilar to Stelara® (ustekinumab)GlobeNewsWire • 02/15/24
Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®GlobeNewsWire • 01/29/24
Alvotech Provides Update on Status of Biologics License Applications for AVT02 and AVT04GlobeNewsWire • 01/19/24
Alvotech Provides Update on Status of Biologics License Applications for AVT02 and AVT04GlobeNewsWire • 01/19/24
STADA and Alvotech Secure Approval for Uzpruvo, Europe's First Ustekinumab Biosimilar to StelaraGlobeNewsWire • 01/10/24
STADA and Alvotech secure approval for Uzpruvo, Europe's first ustekinumab biosimilar to StelaraGlobeNewsWire • 01/10/24
Alvotech Clinical Study Results Demonstrate Therapeutic Equivalence between Biosimilar Candidate AVT06 and Reference Product Eylea® (aflibercept)GlobeNewsWire • 01/03/24
Alvotech (ALVO)'s Technical Outlook is Bright After Key Golden CrossZacks Investment Research • 12/28/23
Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®GlobeNewsWire • 11/29/23
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business UpdateGlobeNewsWire • 11/28/23
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides Business UpdateGlobeNewsWire • 11/28/23
Alvotech to Report Financial Results for the First Nine Months of 2023 on November 28, 2023, and Host Business Update Conference Call on November 29, 2023, at 8:00 am ETGlobeNewsWire • 11/21/23